Skip to content

A study on multimodal improvement of sleep disorders in patients after thyroid surgery by drug-stress regulation

A study on multimodal improvement of sleep disorders in patients after thyroid surgery by drug-stress regulation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129387
Enrollment
Unknown
Registered
2026-08-04
Start date
2026-08-10
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative sleep disorders

Interventions

Intervention group:Standardized anesthesia induction, maintenance and resuscitation protocols were adopted, along with right stellate ganglion block
Control group:Adopt standardized anesthesia induction, maintenance and resuscitation protocols

Sponsors

Hunan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients aged >= 18 years; 2.ASA grade I - III; 3.Undergoing thyroid surgery; 4.Patients or their families are able to provide written informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients who are currently participating in or planning to participate in any interventional clinical trials; 2.Those with communication disorders, consciousness disorders or coma; 3.Those with a history of sleep disorders (PSQI > 7 points); 4.Those with severe OSA; 5.Those with neuropathy; 6.Those with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system diseases; 7.Those with dementia and mental disorders who cannot cooperate; 8.Those who are admitted to the ICU after surgery; 9.Those with possible airway obstruction; 10.Those who experience complications related to nerve block operations or drugs during surgery; 11.Those with failed nerve block; 12.Those who refuse to cooperate or request to withdraw from the study. 13.Situations where planetary ganglion block is not suitable, such as glaucoma, local anesthetic allergy, coagulation disorders, and infection at the puncture site, etc;

Design outcomes

Primary

MeasureTime frame
The incidence of sleep disorders within 1 to 3 days after the surgery;

Secondary

MeasureTime frame
The incidence of respiratory depression after RSG intervention;The occurrence rate of adverse reactions (such as nausea, vomiting, abdominal distension and low blood pressure);Sleep quality 1-3 days after the surgery;The VAS pain score (maximum) 1-3 days after the operation;Sleep quality on the 7th and 30th days after the operation;The incidence of hypotension after RSG blocking;Awakening time (the time from stopping the administration of anesthetic drugs to extubation);Hospitalization period (number of days from admission to discharge);

Countries

China

Contacts

Public ContactWei Lai

Hunan Provincial People's Hospital

448027999@qq.com+86 731 84762689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026